Home/Filings/4/0001192482-20-000068
4//SEC Filing

Murphy Peter C. 4

Accession 0001192482-20-000068

CIK 0001561921other

Filed

Jan 28, 7:00 PM ET

Accepted

Jan 29, 7:14 PM ET

Size

5.4 KB

Accession

0001192482-20-000068

Insider Transaction Report

Form 4
Period: 2020-01-27
Murphy Peter C.
Chief Commercial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2020-01-27+60,00060,000 total
    Exercise: $15.50Exp: 2030-01-27Common Stock (60,000 underlying)
Footnotes (1)
  • [F1]The option vests 25% on January 27, 2021, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continuous service with the Issuer.

Issuer

TELA Bio, Inc.

CIK 0001561921

Entity typeother

Related Parties

1
  • filerCIK 0001801542

Filing Metadata

Form type
4
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 7:14 PM ET
Size
5.4 KB